Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

During a live event, Daniel M. Geynisman, MD, and participants discussed which efficacy end points they value and how they ...